Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001753926-26-000263·Cellectar Biosciences, Inc.
Schedule 13G ownership disclosure
CELLECTAR BIOSCIENCES INC
Common Stock, par value $0.00001 per share · CUSIP: 15117F880
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Hexstone Capital LLC
Shares: 216,130.00 · Class: 4.9%
- Brendan O'Neil
Shares: 216,130.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-26-000263
- Form type
- SCHEDULE 13G/A
- Filer
- Cellectar Biosciences, Inc.
- CIK
- CIK 1279704
- Filed
- Feb 04, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership